Skip navigation

Refine by Type

Refine by Keyword

Results 1 - 10 of 14 for Pralatrexate
  1. Pralatrexate injection is used to treat peripheral T-cell lymphoma (PTCL; a form of cancer that begins ... has come back after treatment with other medications. Pralatrexate injection has not been shown to help people ...
  2. ... chemical change that stops tumor cells from dividing. Pralatrexate is a dihydrofolate reductase (DHFR) inhibitor used to ... folate , a nutrient needed for cells to divide. Pralatrexate may slow the growth of tumors and kill ...
  3. Peripheral T-Cell Lymphoma (Lymphoma Research Foundation) - PDF  
    ... the U.S. Food and Drug Administration (FDA) approved pralatrexate (Folotyn) for the treatment of patients with relapsed ( ... refractory (disease does not respond to treatment) PTCL. Pralatrexate was the first drug approved specifically for patients ...
  4. Cutaneous T Cell Lymphoma (Leukemia & Lymphoma Society) - PDF  
    ... other organs or for those with SS include Methotrexate, pralatrexate (Folotyn®)—anti-folate agents that interfere with the growth of tumor cells; pralatrexate is FDA approved for the treatment of relapsed ...
  5. Drugs Approved for Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    ... Doxorubicin Hydrochloride Folex (Methotrexate) Folex PFS (Methotrexate) Folotyn (Pralatrexate) Ibritumomab Tiuxetan Ibrutinib Idelalisib Imbruvica (Ibrutinib) Intron A ( ...
  6. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... FOLFIRI FOLFIRI-BEVACIZUMAB FOLFIRI-CETUXIMAB FOLFIRINOX FOLFOX Folotyn (Pralatrexate) FU-LV Fulvestrant Back to Top G Gardasil ( ... AQ (Cisplatin) Plerixafor Pomalidomide Pomalyst (Pomalidomide) Ponatinib ... Hydrochloride Proleukin (Aldesleukin) Prolia (Denosumab) Promacta ( ...
  7. Facts Spring 2014 (Leukemia & Lymphoma Society) - PDF  
    ... other tyrosine kinase inhibitor (TKI) therapy is indicated. Pralatrexate (Folotyn ® ) is approved for the treatment of patients ...
  8. Adult T-Cell Leukemia/Lymphoma (HTLV-1) (Lymphoma Research Foundation) - PDF  
    ... emerging as potential treatments for ATLL, including: • PDX (pralatrexate) • Vorinostat (Zolinza) • Lenalidomide (Revlimid) • Bortezomib (Velcade) The role ...
  9. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... vorinostat (Zolinza®) , romidepsin (Istodax®) , bexarotene (Targretin®) , bortezomib (Velcade®) , pralatrexate (Folotyn®) , lenaliomide (Revlimid®) , ibrutinib (Imbruvica™) , siltuximab (Sylvant™) , idelalisib ( ...
  10. Preventing Vomiting Caused by Cancer Treatment (American Society of Clinical Oncology)  
    ... PFS) at higher doses Etoposide (Etopophus, Toposar, VePesid) Pralatrexate (Folotyn) Epirubicin (Ellence) when combined with cyclophosphamide Daunorubicin ...
previous · 1 · 2 · next